AN ANALYTICAL RESEARCH ON THE MOLECULAR PHARMACOLOGICAL PERSPECTIVES OF THE PHARMACODYNAMICS AND PHARMACOKINETICS OF NEWER CANCER ONCOIMMUNOTHERAPEUTICS

Dr. Moumita Hazra*

ABSTRACT

With the rapid development of oncoimmunology, immunotherapy has been approved for the treatment of multiple cancers and has achieved surprising clinical outcomes in recent decades. This analytical research was conducted on the molecular pharmacological perspectives involving the pharmacodynamics and pharmacokinetics of the different types of newer oncoimmunotherapeutic treatment modalities, under various phases of clinical trials, for the treatment of pre-cancers, malignancies and metastases.

Keywords: Cancer oncoimmunotherapies, cell based immunotherapies, oncolytic virus immunotherapies, neoantigen vaccines, nanoparticle-based approaches, polyepitope DNA vaccines, cancer pharmaco-chemo-immuno-therapeutics.